| Yazarlar |
Erdınc Bozkurt
Türkiye |
Dr. Öğr. Üyesi Abdullah GÜMÜŞ
Kafkas Üniversitesi, Türkiye |
|
Yaran Koban
Türkiye |
| Özet |
| Purpose: We aimed to evaluate the relationship between serum endocan levels and diabetic retinopathy (DR) severity in diabetic patients.Material and Method: The study included 72 patients with diabetes mellitus (DM) and 28 volunteer control patients without any systemic disease. Patients with no systemic disease were the 1st group (n=28), diabetic patient without DR were the 2nd group (n=21), patients with non-proliferative DR were 3rd group (n=24) and patients with proliferative DR were 4th group (n=27). BMI, serum endocan levels, HbA1c, urea, creatinine levels and macular thickness were measured. Results: Serum endocan levels were 170.05±85.67, 333.91±13.41, 340.42±105.07, 472.83±147.40 ng/L, respectively. BMI was 23.11±1.37 in the 1st group, 28.05±4.62 in the 2nd group, 29.00±5.69 in the 3rd group, and 28.85±5.88 in the 4th group. HbA1c levels were 4.83±0.55 in 1st group, 6.60±1.15 in 2nd group, 8.49±1.24 in 3rd group, and 8.89±1.30 in 4th group. Macular thickness measured with OCT was 216.96±11.64, 253.29±23.62, 274.88±61.11, 352.93±120.08μm in the right eye and 218.96±11.93, 240.65±17.57, 283±62.89, 334.78±127.71μm in the left eye, respectively.Conclusion: In our study, there was a relationship between serum endocan level and DR stage. Serum endocan level can reveal important information about the severity and stage of DR such as serum creatinine and HbA1c level. There is a potential need for further research to demonstrate whether endocan is involved in DR pathogenesis. |
| Anahtar Kelimeler |
| Makale Türü | Özgün Makale |
| Makale Alt Türü | ESCI dergilerinde yayımlanan tam makale |
| Dergi Adı | RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES |
| Dergi ISSN | 0275-004X |
| Dergi Tarandığı Indeksler | ESCİ |
| Makale Dili | İngilizce |
| Basım Tarihi | 01-2020 |
